Aspen Pharmacare Holdings (STU:LDZA) Other Operating Expense : €258 Mil (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Aspen Pharmacare Holdings Other Operating Expense?

Aspen Pharmacare Holdings's Other Operating Expense for the six months ended in Dec. 2023 was €40 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 was €258 Mil.

Aspen Pharmacare Holdings's quarterly Other Operating Expense increased from Dec. 2022 (€25 Mil) to Jun. 2023 (€217 Mil) but then declined from Jun. 2023 (€217 Mil) to Dec. 2023 (€40 Mil).

Aspen Pharmacare Holdings's annual Other Operating Expense increased from Jun. 2021 (€283 Mil) to Jun. 2022 (€310 Mil) but then declined from Jun. 2022 (€310 Mil) to Jun. 2023 (€240 Mil).

Aspen Pharmacare Holdings Other Operating Expense Historical Data

The historical data trend for Aspen Pharmacare Holdings's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aspen Pharmacare Holdings Other Operating Expense Chart

Aspen Pharmacare Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Other Operating Expense

Get a 7-Day Free Trial

313.83

224.20

282.71

309.92

239.60

Aspen Pharmacare Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Operating Expense	Get a 7-Day Free Trial															30.63	277.02	24.53	217.49	40.06

Aspen Pharmacare Holdings Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €258 Mil.

Aspen Pharmacare Holdings Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Aspen Pharmacare Holdings's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Aspen Pharmacare Holdings (STU:LDZA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aspen Pharmacare Holdings Ltd (STU:LDZA) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

APN:South Africa APNHY:USA

Address

Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF

Website

https://www.aspenpharma.com

Aspen Pharmacare Holdings Ltd is a specialty pharmaceutical company with a commercial footprint covering more than 50 countries and complex manufacturing capabilities in both API and finished dose form. The company focuses on a broad range of post-patent, branded medicines and domestic brands spanning many therapeutic areas. The company has four business segments such as Active Pharmaceutical Ingredients (API) - this segment includes the API Chemicals business and non-heparin biochemical API business, Heparin - this segment includes the full value chain contribution from all heparin containing products including API and Finished Dose. Form (FDF) sales Key products include the Fraxiparine and MonoEmbolex heparin containing FDF products and FDF Steriles segment.

Aspen Pharmacare Holdings (STU:LDZA) Headlines

No Headlines